|Home||» Products||» Anti Cancer Drugs||» Erlonat 150MG ( ERLOTINIB 150 MG)|
PRODUCT OF NATCO COMPANY - ERLONAT
Erlonat belongs to a class of medications called Kinase inhibitors and contains erlotinib. It is used for the treatment of non-small cell lung cancer and in combination with Gemcitabine, is used for the treatment of pancreatic cancer which spreads to adjacent tissues of the body. The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells
Available in 25 mg, 100 mg & 150 mg tablets
Usually 150 mg tablet is administered, at least an hour before or two hours after the ingestion of food, for curing pancreatic non-small cell lung cancer. Erlonat is usually given as 100 mg tablets, at least an hour before or two hours after the intake of food, for curing of pancreatic cancer, in combination with gemcitabine.
Symptoms of overdose may include diarrhea and rash
Precautions and warnings
The following drugs may interact with Erlonat:
Side effects of the medicine are as follows:
Note: Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.